Supplementary Figure S6 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation | Synapse
September 4, 2024
Supplementary Figure S6 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S6 shows single-cell RNA sequencing data from 5 HGSC tumors, with cell-specific markers and EHMT1 and EHMT2.